| 3 min read
Starting from a defined mechanism can cause discovery programs to miss the best drug candidates.
| 3 min read
Researchers at Erasmus MC and Apeximmune independently identified PLA2G2D as a potential new target for restoring antitumor T cell responses.
| 7 min read
This year’s awardees were recognized for their achievements in the discovery of orexin, the development of a novel bispecific antibody, and bringing patients to the forefront of drug discovery.
| 4 min read
Whole-exome sequencing identified 36 genes associated with OCD and chronic tic disorders, expanding researchers’ understanding of the biology underlying both conditions.
| 4 min read
The first gene therapy for Huntington's disease submitted to the FDA, an mRNA flu vaccine advances to Phase 3 trials, an antibody drug for celiac disease, and more led the news this week.News
| 2 min read
The newly discovered cells protect the tumor by recruiting regulatory T cells to create an immunosuppressive environment.
| 3 min read
The novel stem-cell derived retinal organoid provided a new understanding of the disease by showing that damage to retinal pigment epithelium cells is enough to cause neurodegeneration of photoreceptors.
| 4 min read
Neuro-Innovators is testing whether a combination of existing medicines can promote neuroplasticity and improve outcomes for people living with chronic stroke disability.
| 4 min read
Another FDA-approved blood test for Alzheimer’s disease, a large investment in an epilepsy drug, a win for a monoclonal antibody drug, and more led the news this week.
| 6 min read
Bacteria have been linked to cancer treatment for more than a century. Now researchers are trying to turn them into actual therapies.
| 3 min read
New results from their Phase 2 trials show promise, but there could be issues moving to Phase 3. GSK's functional cure could be approved in the US before then.
Cancer Research News
A newly certified DPYD genotyping assay gives oncologists a validated way to flag chemotherapy toxicity risk before treatment starts
The science behind personalized mRNA cancer vaccines is working. Building a different drug for every patient, at scale, is the real fight.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Repetitive pipetting can strain the hands, wrists, shoulders, and neck, making ergonomics an important part of efficient liquid handling.
Explore how high-dimensional flow cytometry can expand immune profiling and support immunotoxicology assessment during preclinical drug development.
